___

• Guyatt G, Veldhuyzen Van Zanten S, Feeny D, Patrick
• D. Measuring quality of life in clinical trials: a taxonomy
• and review. Can Med Assoc J 1989; 140: 1441-1448.
• Lauper P, Versteegen U. The importance of quality of
• life in policy decisions: new end points in medical
• outcome assessment. Pharm Med 1992; 5: 43-50.
• Schumacher A, Kessler T, Riedel A, Buchner T, van de
• Loo J. Quality of life and coping with illness in patients
• with acute myeloid leukemia. Psychother Psychosom
• Med Psychol 1996; 46: 385-390.
• Jerkeman M, Kaasa S, Hjermstad M, Kvaloy S,
• Cavallin-Stahl E. Health-related quality of life and its
• potential prognostic implications in patients with
• aggressive lymphoma: a Nordic Lymphoma Group Trial.
• Medical Oncology 2001; 18: 85-94.
• Persson L, Larsson G, Ohlsson O, Hallberg IR. Acute
• leukemia or highly malignant lymphoma patients’
• quality of life over two years: a pilot study. Eur J of
• Cancer Care 2001; 10: 36-47.
• Cella DF, Tulsky S. Measuring quality of life today:
• methodological aspects. Oncology 1990; 4: 29-38.
• The WHOQOL Group. The World Health Organization
• quality of life assessment (WHOQOL): position paper
• from the World Health Organization. Soc Sci Med 1995;
• : 1403-1409.
• Gotay CC, Korn EL, McCabe MS, Moore TD, Cheson
• BD. Quality-of-life assessment in cancer treatment
• protocols: research issues in protocol development. J
• Natl Cancer Inst 1992; 84: 575-579.
• Cella DF. Quality of life: the concept. J Palliat Care
• ; 8: 8-13.
• Kaasa S, Loge JH. Quality of life in palliative care:
• principles and practice. Palliat Med 2003; 17: 11-20.
• Wierzbicka M, Kusnierkiewicz M, Wojtowicz JG,
• Maune S, Szyfter W. The quality of life in head and neck
• cancer patients: description of randomized examination
• formula based on standardized questionnaires EORTC
• QLQ C-30, EORTC QTQ-H-N35 and Kiel
• Questionnaire. Otolaryngol Pol 2001; 55: 287-292 [in
• Polish].
• Kaasa S, Bjordal K, Aaronson N, et al. The EORTC
• core quality of life questionnaire (QLQ-C30): validity
• and reliability when analyzed with patients treated with
• palliative radiotherapy. Eur J Cancer 1995; 31A: 2260-
• -
• Kobayashi K, Takeda F, Teramukai S, et al. A crossvalidation
• of the European Organization for Research
• and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30)
• for Japanese with lung cancer. Eur J Cancer 1998; 34:
• –815.
• Osoba D, Aaronson N, Zee B, Sprangers M, te Velde A.
• Modification of the EORTC QLQ-C30 (version 2.0)
• based on content validity and reliability testing in large
• samples of patients with cancer. The Study Group on
• Quality of Life of the EORTC and the Symptom Control
• and Quality of Life Committees of the NCI of Canada
• Clinical Trials Group. Qual Life Res 1997; 6: 103-108.
• Aaronson NK, Ahmedzai S, Bergman B, et al. The
• European Organization for Research and Treatment of
• Cancer QLQ-C30: a quality-of-life instrument for use in
• international clinical trials in oncology. J Natl Cancer
• Inst 1993; 85: 365-376.
• Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al.
• Development of a European Organization for Research
• and Treatment of Cancer (EORTC) questionnaire
• module to be used in quality of life assessments in head
• and neck cancer patients. EORTC Quality of Life Study
• Group. Acta Oncol 1994; 33: 879-885.
• Bjordal K, de Graeff A, Fayers PM, et al. A 12 country
• field study of the EORTC QLQ-C30 (version 3.0) and
• the head and neck cancer specific module (EORTC
• QLQ-H&N35) in head and neck patients. EORTC
• Quality of Life Group. Eur J Cancer 2000; 36: 1796-
• -
• Blazeby JM, Alderson D, Winstone K, et al.
• Development of an EORTC questionnaire module to be
• used in quality of life assessment for patients with
• oesophageal cancer. The EORTC Quality of Life Study
• Group. Eur J Cancer 1996; 32A: 1912-1917.
• Sprangers MA, Cull A, Groenvold M, Bjordal K,
• Blazeby J, Aaronson NK. The European Organization
• for Research and Treatment of Cancer approach to
• developing questionnaire modules: an update and
• overview. EORTC Quality of Life Study Group. Qual
• Life Res 1998; 7: 291-300.
• Schumacher A, Kessler T, Buchner T, Wewers D, van
• de Loo J. Quality of life in adult patients with acute
• myeloid leukemia receiving intensive and prolonged
• chemotherapy-a longitudinal study. Leukemia 1998; 12:
• -592.
• Ruffer JU, Flechtner H, Tralls P, et al. Fatigue in longterm
• survivors of Hodgkin‘s lymphoma; a report from
• the German Hodgkin Lymphoma Study Group (GHSG).
• Eur J Cancer 2003; 39: 2179-2186.
• Vogelzang NJ, Breitbart W, Cella D, et al. Patient,
• caregiver, and oncologist perceptions of cancer-related
• fatigue: results of a tripart assessment survey. The
• Fatigue Coalition. Semin Hematol 1997; 34: 4-12.
• Curt GA. The impact of fatigue on patients with cancer:
• overview of FATIGUE 1 and 2. Oncologist 2000; 5
• (Suppl 2): 9-12.